Healthpeak Properties vs Healthcare Realty Trust
DOC and HR side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOC and HR compare
Healthpeak Properties is the larger company, worth 2.1 times as much as Healthcare Realty Trust ($14.1B against $6.6B).
Healthpeak Properties grew revenue faster over the last twelve months (5.5% versus −5.8% for Healthcare Realty Trust).
Healthpeak Properties keeps more of each dollar of sales as profit, with a net margin of 8.2% compared with −4.0% at Healthcare Realty Trust.
Both pay dividends: Healthpeak Properties yields 6.0% and Healthcare Realty Trust 3.7%.
Healthpeak Properties scores higher on the StockData Score (8 against 3 for Healthcare Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOC | HR |
|---|---|---|
| Size and price | ||
| Market cap | $14.1B | $6.6B |
| Share price | $20.38 | $19.35 |
| Change, 1 year | 15.1% | 6.9% |
| Change, 5 years | −40.4% | −40.7% |
| Beta (5Y) | 0.71 | 0.51 |
| Employees | 411 | 539 |
| StockData Score | ||
| Total score | 8 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 4 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 0 | 0 |
| Dividend score | 3 (better) | 1 |
| Valuation | ||
| P/E | 58.2× | – |
| P/S | 4.8× (better) | 5.8× |
| P/B | 1.8× | 1.6× (better) |
| EV/EBITDA | 7.5× | – |
| Fair value | $16.85 | $16.75 |
| Margin of safety | −20.9% | −15.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.5% (better) | −5.8% |
| Revenue growth, 5Y average | 11.4% | 18.8% (better) |
| Net income growth (TTM) | 47.5% | – |
| EPS growth (TTM) | 45.8% | – |
| EPS growth, 5Y average | −33.5% | – |
| Profitability | ||
| Net margin | 8.2% (better) | −4.0% |
| Return on equity | 3.1% (better) | −1.0% |
| Financial health | ||
| Altman Z-score | 0.83 | 0.94 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.0% (better) | 3.7% |
| Payout ratio | 348% | – |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | −3.8% | −1.7% (better) |
| Buyback yield | 0.72% (better) | 0.05% |
| Shareholder yield | 6.7% (better) | 3.8% |
| Ownership | ||
| Held by institutions | 95.9% | 112% |
| Held by insiders | 0.34% | 5.0% |
| Insider net buying, 12 months | −$341K (better) | −$745K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 3.3% | 5.3% |
Go deeper
- DOC stock overview
- DOC income statement
- DOC valuation and score
- HR stock overview
- HR income statement
- HR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.